Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Moss GenomicsFRA:F73 Market Cap is €1.37 Mil as of Jul. 21, 2026. Among 695 Healthcare Providers & Services companies, Moss Genomics ranks worse than 96.26% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Moss Genomics's share price for the quarter that ended in Mar. 2026 was €0.027. Moss Genomics's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 63.42 Mil. Therefore, Moss Genomics's market cap for the quarter that ended in Mar. 2026 was €1.71 Mil.
Moss Genomics's quarterly market cap
declined
from Sep. 2025 (€1.67 Mil) to Dec. 2025 (€1.08 Mil) but then
increased
from Dec. 2025 (€1.08 Mil) to Mar. 2026 (€1.71 Mil).
Moss Genomics's annual market cap
stayed the same
from Jun. 2023 (€0.00 Mil) to Jun. 2024 (€0.00 Mil) but then
increased
from Jun. 2024 (€0.00 Mil) to Jun. 2025 (€4.62 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Moss Genomics's Enterprise Value for Today is €1.34 Mil.
Moss Genomics (FRA:F73) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Moss Genomics Market Cap Related Terms
Moss Genomics Market Cap Historical Data
* Premium members only.
The historical data trend for Moss Genomics's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Moss Genomics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Moss Genomics Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Moss Genomics's Market Cap distribution charts can be found below:
* The bar in red indicates where Moss Genomics's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Moss Genomics's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Moss Genomics (FRA:F73) has a Market Cap of €1.37 Mil as of Jul. 21, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Moss Genomics and its competitors. According to the industry distribution chart, Moss Genomics ranks #669 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 96.3%.
Is Moss Genomics' Market Cap too high?
Moss Genomics' current Market Cap is €1.37 Mil. Based on the distribution chart, Moss Genomics ranks #669 out of 695 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Moss Genomics' Market Cap compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Moss Genomics ranks #669 out of 695 companies for Market Cap. This places Moss Genomics in the lower half of its industry. The industry median Market Cap is 103.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 103.63, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Moss Genomics and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 103.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Moss Genomics's current Market Cap is €1.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moss Genomics stock overvalued right now?
Moss Genomics (FRA:F73) has a current Market Cap of €1.37 Mil. The current Market Cap is €1.37 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Moss Genomics (FRA:F73), the current Market Cap is €1.37 Mil as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Moss Genomics Inc is an emerging consumer genomics company that provides personalized health, anti-aging, and wellness solutions based on genomic, microbiome, and epigenome data. It aims to eliminate barriers in healthcare by offering accessible, affordable at-home testing along with easy-to-understand actionable results.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:F73 has been successfully added to your 
